Coeptis Therapeutics Holdings Inc.
COEP • NASDAQ
Coeptis Therapeutics Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Mehalick, with a market cap of $78.5M.
Market Cap$78.5M
Employees7.0
CEODavid Mehalick
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Coeptis Therapeutics Holdings Inc. FAQ
Common questions about Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Coeptis Therapeutics Holdings Inc. has approximately 7 employees.